Menu
CareerMVP
  • Home
  • Search
    • Jobs
    • News
  • Post
    • Nominate
    • Membership
    • Post Jobs
  • Channels
    • BusinessMVP
    • Local Career Sites
    • Trade Publications
    • Local Publications
Close Menu

Mylan Launches Generic Actonel® Tablets, 150 mg

Health, Medical, Pharmaceuticals, Press Releases

PITTSBURGH, June 11, 2014 /PRNewswire/ — Mylan Inc. (Nasdaq: MYL) today announced that it has launched Risedronate Sodium Tablets USP, 150 mg, the generic version of Warner Chilcott’s Actonel® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Risedronate Sodium Tablets USP, 150 mg, had U.S. sales of approximately $171.6 million for the 12 months ending March 31, 2014, according to IMS Health.

Currently, Mylan has 303 ANDAs pending FDA approval representing $105.3 billion in annual brand sales, according to IMS Health. Forty-one of these pending ANDAs are potential first-to-file opportunities, representing $25.4 billion in annual brand sales, for the 12 months ending Dec. 31, 2013, according to IMS Health.

Mylan is a global pharmaceutical company committed to setting new standards in health care. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what’s right, not what’s easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 1,300 generic pharmaceuticals and several brand medications. In addition, we offer a wide range of antiretroviral therapies, upon which approximately 40% of HIV/AIDS patients in developing countries depend. We also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in approximately 140 countries and territories. Our workforce of more than 20,000 people is dedicated to improving the customer experience and increasing pharmaceutical access to consumers around the world. But don’t take our word for it. See for yourself. See inside. mylan.com

SOURCE Mylan Inc.

Related Posts

Press Releases

Dollar General to Hire Up to 50,000 New Employees to Support Operations

Press Releases

Dollar General Announces Approximately $35 Million Investment in Employees, 50,000 New Hires

Press Releases

U.S. Bank announces 20% Premium Pay Program for employees and $30M commitment to support individual and small business recovery

Featured Jobs

  • Full Time Courier Delivery Driver-Swing, $18.86 HR with Benefits

    • Pierre, SD
    • FedEx Express
    • Full Time
  • Fleet Technician A

    • San Jose, CA
    • Reyes Fleet Management
    • Full Time

Featured News

  • Dollar General to Hire Up to 50,000 New Employees to Support Operations
  • Dollar General Announces Approximately $35 Million Investment in Employees, 50,000 New Hires
  • U.S. Bank announces 20% Premium Pay Program for employees and $30M commitment to support individual and small business recovery
  • CVS Health to provide bonuses, add benefits and hire 50,000 in response to pandemic
  • Papa John’s to Hire 20,000 New Team Members Immediately
Back To Top
CareerMVP
Copyright © BusinessMVP.com
All Rights Reserved!